These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 17357887)

  • 1. First Diquafosol Treatment for Dry Eye: 10-Year Follow-Up.
    Koh S; Soma T; Oie Y; Nishida K
    Asia Pac J Ophthalmol (Phila); 2023 Jan-Feb 01; 12(1):103-104. PubMed ID: 35342178
    [No Abstract]   [Full Text] [Related]  

  • 2. Concerns About a Dog Model of Dry Eye Disease.
    Ofri R; Millichamp NJ; Keller C; McLellan GJ; Komáromy AM; Morton D; Matas M; Michau TM; Coall S; Sansom J; Leonard BC
    Transl Vis Sci Technol; 2024 Mar; 13(3):28. PubMed ID: 38547120
    [No Abstract]   [Full Text] [Related]  

  • 3. ChatGPT as a tool for conducting literature review for dry eye disease.
    Singh S; Watson S
    Clin Exp Ophthalmol; 2023; 51(7):731-732. PubMed ID: 37321598
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent developments on dry eye disease treatment compounds.
    Colligris B; Alkozi HA; Pintor J
    Saudi J Ophthalmol; 2014 Jan; 28(1):19-30. PubMed ID: 24526854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
    Shigeyasu C; Yamada M; Akune Y; Tsubota K
    Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
    Hwang HS; Sung YM; Lee WS; Kim EC
    Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised, parallel-group comparison study of diquafosol ophthalmic solution in patients with dry eye in China and Singapore.
    Gong L; Sun X; Ma Z; Wang Q; Xu X; Chen X; Shao Y; Yao K; Tang L; Gu Y; Yuan H; Chua WH; Chuan JC; Tong L
    Br J Ophthalmol; 2015 Jul; 99(7):903-8. PubMed ID: 25631485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
    Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
    Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A molecular marker for dry eye].
    Pintor J
    Arch Soc Esp Oftalmol; 2007 Mar; 82(3):129-30. PubMed ID: 17357887
    [No Abstract]   [Full Text] [Related]  

  • 10. Diquafosol tetrasodium: a novel dry eye therapy.
    Nichols KK; Yerxa B; Kellerman DJ
    Expert Opin Investig Drugs; 2004 Jan; 13(1):47-54. PubMed ID: 14680452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diquafosol ophthalmic solution for dry eye treatment.
    Nakamura M; Imanaka T; Sakamoto A
    Adv Ther; 2012 Jul; 29(7):579-89. PubMed ID: 22843206
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.